These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22233302)

  • 1. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.
    Kuyucu T; Güçlü SZ; Saylan B; Demir C; Senol T; Güner S; Koyuncu E; Ozen F; Oztürk S; Cangül Z; Ağanoğlu S; Ozkaya S; Ocak SC; Akkurt H; Intepe YS; Bayrak MG; Güler T; Bekçi TT; Soyyiğit S; Seyfettin S; Kula O; Akbay MO; Büyükgöze B; Asal G; Başlilar S; Oztürk O;
    Tuberk Toraks; 2011; 59(4):328-39. PubMed ID: 22233302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study.
    Polatlı M; Bilgin C; Şaylan B; Başlılar Ş; Toprak E; Ergen H; Bakan ND; Kart L; Kılıç Z; Üstünel A; Şengün A; Varol Y; Yılmaz A; Ataol Ç; Bulgur D; Bozdoğan S; Tunaboyu İ; Özkan ZG; Uysal E; Gülgösteren S; Akın N; Selim Y; Irmak M; Turgut E; Keskin O; Bektaş Uysal H; Sofuoğlu N; Yılmaz M;
    Tuberk Toraks; 2012; 60(1):1-12. PubMed ID: 22554361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom variability in patients with severe COPD: a pan-European cross-sectional study.
    Kessler R; Partridge MR; Miravitlles M; Cazzola M; Vogelmeier C; Leynaud D; Ostinelli J
    Eur Respir J; 2011 Feb; 37(2):264-72. PubMed ID: 21115606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.
    Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
    Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Miravitlles M; Menezes A; López Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Wehrmeister FC; Surmont F; Montes de Oca M
    Respir Med; 2018 Jan; 134():62-69. PubMed ID: 29413510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG.
    Tsiligianni I; Metting E; van der Molen T; Chavannes N; Kocks J
    NPJ Prim Care Respir Med; 2016 Jul; 26():16040. PubMed ID: 27442618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
    Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
    Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
    Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG
    Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
    Kulich K; Keininger DL; Tiplady B; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The variability of respiratory symptoms and associated factors in COPD.
    Miravitlles M; Izquierdo JL; Esquinas C; Pérez M; Calle M; López-Campos JL; Rodríguez González-Moro JM; Casanova C; Esteban C; de Lucas P
    Respir Med; 2017 Aug; 129():165-172. PubMed ID: 28732827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common lung conditions: chronic obstructive pulmonary disease.
    Delzell JE
    FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
    Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H
    Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD.
    Marth K; Schuller E; Pohl W
    Respir Med; 2015 May; 109(5):616-24. PubMed ID: 25796962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.